ArticleLa Radiologia medica2025
Virtual biopsy through CT imaging: can radiomics differentiate between subtypes of non-small cell lung cancer?
Article in La Radiologia medica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
objectiveThis study evaluated the performance of CT radiomics in distinguishing between lung adenocarcinoma (ADC) and squamous cell carcinoma (SCC) at baseline imaging, exploring its potential as a noninvasive virtual biopsy. MATERIALS AND
methodsA retrospective analysis was conducted, enrolling 330 patients between September 2015 and January 2023. Inclusion criteria were histologically proven ADC or SCC and baseline contrast-enhanced chest CT. Exclusion criteria included significant motion artifacts and nodules < 6 mm. Radiological features, including lung lobe affected, peripheral/central location, presence of emphysema, and T/N radiological stage, were assessed for each patient. Volumetric segmentation of lung cancers was performed on baseline CT scans at the portal-venous phase using 3DSlicer software (v5.2.2). A total of 107 radiomic features were extracted and selected using the least absolute shrinkage and selection operator (LASSO) and tenfold cross-validation. Multivariable logistic regression analysis was employed to develop three predictive models: radiological features-only, radiomics-only, and a combined model, with statistical significance set at p < 0.05. Additionally, an independent external validation cohort of 16 patients, meeting the same inclusion and exclusion criteria, was identified.
resultsThe final cohort comprised 200 ADC and 100 SCC patients (mean age 68 ± 10 years, 184 men). Two radiological and 21 radiomic features were selected (p < 0.001). The Radiological model achieved AUC 0.73 (95% CI 0.68-0.78, p < 0.001), 72.3% accuracy. The radiomics model achieved AUC 0.80 (95% CI 0.75-0.85, p < 0.001), 75.6% accuracy. The combined model achieved AUC 0.84 (95% CI 0.80-0.88, p < 0.001), 75.3% accuracy. External validation (n = 15) yielded AUC 0.78 (p = 0.05).
conclusionThe combined radiologic-radiomics model showed the best performance in differentiating ADC from SCC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.